Close Menu


Snyder directs the new Center for Genomics and Personalized Medicine at Stanford, which aims to integrate genomic information with medicine. Large-scale genome sequencing will play an important role in the effort.

A Stanford University research team reported today that they have uncovered apparent connections between histone methylation, reproduction, and life span in C. elegans worms.

At the European Society of Human Genetics meeting in Sweden this weekend, researchers described their efforts to sequence and characterize African-American and Hispanic-Latino genomes.

The new center will combine biological and computational research to reconstruct molecular networks in the study of non-solid tumors, as well as establish resources for complex data analysis, and for education and outreach to Stanford's cancer research community.

The university will pilot a summer elective course on genetics that includes several precautionary measures to ensure that students don't feel coerced to participate. The incorporation of this course as a permanent program will depend on the success of this pilot, the university said.

The university said students will learn how to analyze, evaluate, and interpret the genetic data, the limitations of existing technologies, and the legal and ethical issues surrounding personal genotyping.

Stanford says the center will build on research from the sequencing of the genome of bioengineering professor Stephen Quake, as well as draw on collaborations between Stanford's basic scientists and clinical researchers, and on technologies developed in Silicon Valley.

Despite criticism, UC Berkeley shows no signs of halting its proposed plans to genetically test incoming freshman this fall. Although UC Berkeley is the first to attempt to roll out genetic testing within its student body, other campuses around the country are planning similar projects.

For early adopters, there are many reasons to be excited about the potential of whole-genome sequencing to broadly personalize healthcare. But for some public health observers, the analytical and educational challenges present an overwhelming hurdle.

Researchers from Stanford and Harvard Universities reported today that they have scoured an individual's whole-genome sequence for clinically useful information.


The Wall Street Journal reports that Russia's announcement of a coronavirus vaccine approval was met with concern as safety testing has not yet been completed.

New Scientist writes there aren't much data available on the accuracy of the two rapid COVID-19 tests the UK plans to roll out.

In PNAS this week: downstream effect of oncoprotein fusion, epigenetic changes influence tRNAs in colon cancer, and more.

Nature News reports that recent proposed changes to the US National Science Foundation have raised concerns about a shift away from the agency's focus on basic research.